Ascendis Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ascendis pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ascendis Pharma Today - Breaking & Trending Today

Avoro Capital Advisors LLC Increases Stock Holdings in Ascendis Pharma A/S (NASDAQ:ASND)

Avoro Capital Advisors LLC raised its holdings in Ascendis Pharma A/S (NASDAQ:ASND – Free Report) by 2.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,755,555 shares of the biotechnology company’s stock after buying an additional 85,555 shares during the quarter. Ascendis Pharma A/S […] ....

United States , Ascendis Pharma , Massachusetts Financial Services Co , Westfield Capital Management Co , First Turn Management , Avoro Capital Advisors , Jpmorgan Chase Co , Morgan Stanley , Wells Fargo Company , Cantor Fitzgerald , Free Report , Capital Advisors , Point Capital , Financial Services , Capital Management , Turn Management , Wells Fargo , Get Free Report , Visit Holdingschannel ,

Seven Eight Capital LP Takes Position in Ascendis Pharma A/S (NASDAQ:ASND)

Seven Eight Capital LP purchased a new stake in shares of Ascendis Pharma A/S (NASDAQ:ASND – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 18,636 shares of the biotechnology company’s stock, valued at approximately $2,347,000. A number of […] ....

United States , Stifel Nicolaus , Ascendis Pharma , Westfield Capital Management Co , Exchange Commission , First Turn Management , Ascendis Pharmaas Company Profile , Morgan Stanley , Wells Fargo Company , Massachusetts Financial Services Co , Jpmorgan Chase Co , Seven Eight Capital , Free Report , Point Capital , Financial Services , Capital Management , Turn Management , Get Free Report , Visit Holdingschannel ,

Ascendis Pharma A/S (NASDAQ:ASND) Short Interest Down 6.5% in May

Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 3,460,000 shares, a decline of 6.5% from the April 30th total of 3,700,000 shares. Based on an average daily volume of 370,500 shares, […] ....

United States , Stifel Nicolaus , Ascendis Pharma , Wells Fargo Company , Avoro Capital Advisors , Morgan Stanley , Massachusetts Financial Services Co , Capital International Investors , Pricet Rowe Associates Inc , Westfield Capital Management Co , Get Free Report , Capital Management , Capital Advisors , International Investors , Massachusetts Financial Services , Financial Services ,

Endocrinology Month in Review: May 2024

Our endocrinology month in review for May 2024 highlights pipeline news in endocrinology and spotlights our coverage of the landmark FLOW trial from ERA 2024. ....

United Kingdom , Ascendis Pharma , Vlado Perkovic , Regulatory Agency , Harvard Medical School , Euroiepean Renal Association Congress , Drug Administration , Corcept Therapeutics , Euroiepean Renal Association ,

Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

04.06.2024 - COPENHAGEN, Denmark, June 04, 2024 (GLOBE NEWSWIRE) - Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, . ....

United States , Ascendis Pharma , Goldman Sachs , Annual Global Healthcare Conference ,